Chemomab Therapeutics Income Statement (2017-2025) | CMMB

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Operating items
Research & Development (Quarter)	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.01B	0.01B	0.01B	0.01B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Selling, General & Administrative (Quarter)	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Restructuring Costs (Quarter)
Other Operating Expenses (Quarter)
Operating Expenses (Quarter)	0.00B	0.00B	0.00B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Operating Income (Quarter)
EBIT (Quarter)	-0.00B	-0.00B	-0.00B	0.03B	-0.01B	0.01B	0.01B	0.05B	0.01B	0.01B	0.00B	0.05B	0.00B	0.00B	0.00B	377.18B			0.00B	625.73B
Non-operating items
Other Non Operating Income (Quarter)	-0.00B	-0.00B	-0.00B	-0.00B	0.00B	-0.00B	0.00B		0.00B
Non Operating Income (Quarter)						0.00B	-0.00B	-0.00B	0.00B	0.00B	-0.00B	-0.00B	0.00B	0.00B	0.00B	-0.00B	0.00B	0.00B	0.00B	-0.00B
Net income details
EBT (Quarter)	-0.00B	-0.00B	-0.00B	-0.01B	-0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.00B	0.00B	0.00B	0.00B	0.00B	377.13B			0.00B	625.68B
Tax Provisions (Quarter)						-0.00B		0.00B	0.00B	0.00B	-0.00B
Profit After Tax (Quarter)	-0.00B	-0.00B	-0.00B	-0.01B	-0.01B	0.01B	0.01B	-0.05B	0.01B	0.01B	0.00B	-0.05B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Income from Continuing Operations (Quarter)	-0.00B	-0.00B	-0.00B	-0.01B	-0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.00B	0.00B	0.00B	0.00B	0.00B	377.13B			0.00B	625.68B
Income from Discontinued Operations (Quarter)
Consolidated Net Income (Quarter)	-0.00B	-0.00B	-0.00B	-0.01B	-0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.00B	0.00B	0.00B	0.00B	0.00B	377.13B			0.00B	625.68B
Income towards Parent Company (Quarter)	-0.00B	-0.00B	-0.00B	-0.01B	-0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.00B	0.00B	0.00B	0.00B	0.00B	377.13B			0.00B	625.68B
Net Income towards Common Stockholders (Quarter)	-0.00B	-0.00B	-0.00B	-0.01B	-0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.00B	0.00B	0.00B	0.00B	0.00B	377.13B			0.00B	625.68B
Additional items
EPS (Basic) (Quarter)	0.00	0.00	0.00	-0.01	-0.01	0.01	0.01	0.01	0.01	0.01	0.00	0.00	0.00	0.00	0.01	262.59			0.00	0.00B
EPS (Diluted) (Quarter)	-0.18	0.00	0.00	-0.01	-0.01	0.01	0.01	0.01	0.01	0.01	0.00	0.00	0.00	0.00	0.00	262.59			0.00	0.00B
Shares Outstanding (Quarter)	0.63B	0.87B	0.91B	0.83B	0.91B	0.91B	0.92B	0.91B	0.88B	0.89B	0.89B	0.94B	1.14B	1.14B	0.35B	1.44B	1.44B	1.84B	0.49B	0.51B
Shares Outstanding (Diluted) (Quarter)	0.01B	0.87B	0.91B	0.83B	0.91B	0.91B	0.92B	0.91B	0.88B	0.89B	0.89B	0.94B	0.94B	1.14B	1.14B	1.44B	1.44B	1.84B	1.84B	0.51B
Shares Outstanding (Entity) (Quarter)	0.06B	0.09B	0.09B	0.08B	0.09B	0.09B	0.09B	0.09B	0.09B	0.09B
EBITDA (Quarter)	-0.00B	-0.00B	-0.00B	0.03B	-0.01B	0.01B	0.01B	0.05B	0.01B	0.01B	0.00B	0.05B	0.00B	0.00B	0.00B	377.18B			0.00B	625.73B
Interest Expenses (Quarter)				0.04B				0.04B				0.04B				0.04B				0.05B
Tax Rate (Quarter)						-8.08%		0.12%	0.24%	0.43%	-1.33%

Research Tools

Developers

Chemomab Therapeutics Income Statement (2017-2025) | CMMB

Research Tools

Developers

Chemomab Therapeutics Income Statement (2017-2025) | CMMB

Create an account

Sign In

Reset Password